OCUL
Price
$12.16
Change
-$0.28 (-2.25%)
Updated
Sep 17 closing price
Capitalization
2.16B
53 days until earnings call
TVTX
Price
$23.65
Change
+$0.88 (+3.86%)
Updated
Sep 17 closing price
Capitalization
2.03B
48 days until earnings call
Interact to see
Advertisement

OCUL vs TVTX

Header iconOCUL vs TVTX Comparison
Open Charts OCUL vs TVTXBanner chart's image
Ocular Therapeutix
Price$12.16
Change-$0.28 (-2.25%)
Volume$2.04M
Capitalization2.16B
Travere Therapeutics
Price$23.65
Change+$0.88 (+3.86%)
Volume$2.01M
Capitalization2.03B
OCUL vs TVTX Comparison Chart in %
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. TVTX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Hold and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (OCUL: $12.16 vs. TVTX: $23.65)
Brand notoriety: OCUL and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 93% vs. TVTX: 101%
Market capitalization -- OCUL: $2.16B vs. TVTX: $2.03B
OCUL [@Biotechnology] is valued at $2.16B. TVTX’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 3 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • OCUL’s TA Score: 3 bullish, 5 bearish.
  • TVTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TVTX is a better buy in the short-term than OCUL.

Price Growth

OCUL (@Biotechnology) experienced а -6.78% price change this week, while TVTX (@Biotechnology) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

OCUL is expected to report earnings on Nov 10, 2025.

TVTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.16B) has a higher market cap than TVTX($2.03B). OCUL YTD gains are higher at: 42.447 vs. TVTX (35.763). TVTX has higher annual earnings (EBITDA): -107.65M vs. OCUL (-200.5M). OCUL has more cash in the bank: 391M vs. TVTX (320M). OCUL has less debt than TVTX: OCUL (76.9M) vs TVTX (400M). TVTX has higher revenues than OCUL: TVTX (334M) vs OCUL (56.7M).
OCULTVTXOCUL / TVTX
Capitalization2.16B2.03B107%
EBITDA-200.5M-107.65M186%
Gain YTD42.44735.763119%
P/E RatioN/AN/A-
Revenue56.7M334M17%
Total Cash391M320M122%
Total Debt76.9M400M19%
FUNDAMENTALS RATINGS
OCUL vs TVTX: Fundamental Ratings
OCUL
TVTX
OUTLOOK RATING
1..100
7783
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
8584
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3939
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCUL's Valuation (53) in the Pharmaceuticals Other industry is somewhat better than the same rating for TVTX (90) in the Biotechnology industry. This means that OCUL’s stock grew somewhat faster than TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as OCUL (85) in the Pharmaceuticals Other industry. This means that TVTX’s stock grew similarly to OCUL’s over the last 12 months.

OCUL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as TVTX (100) in the Biotechnology industry. This means that OCUL’s stock grew similarly to TVTX’s over the last 12 months.

OCUL's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as TVTX (39) in the Biotechnology industry. This means that OCUL’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for OCUL (100) in the Pharmaceuticals Other industry. This means that TVTX’s stock grew somewhat faster than OCUL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OCULTVTX
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STSEX2636.84N/A
N/A
BlackRock Exchange BlackRock
PLCIX68.33N/A
N/A
Voya Large-Cap Growth I
IEOPX13.69N/A
N/A
Voya Large Cap Growth Port A
KBIWX12.07N/A
N/A
KBI Global Investors Aquarius Instl
MLRTX10.62-0.04
-0.38%
NYLI Winslow Large Cap Growth Class R2

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+3.86%
CRNX - TVTX
43%
Loosely correlated
+0.29%
ELVN - TVTX
40%
Loosely correlated
+3.17%
DNLI - TVTX
39%
Loosely correlated
-1.51%
XNCR - TVTX
38%
Loosely correlated
+7.31%
OCUL - TVTX
38%
Loosely correlated
-2.17%
More